Milwaukee,WI
The Society for Clinical Data Management recently published Edit Check Design Principles, a collection of best practices for the creation of edit checks-a key tool for efficiency and data quality.
The chapter is a new addition to SCDM’s Good Clinical Data Management Practices(GCDMP), an award-winning resource for clinical data managers and others involved in medical device, biotechnology, and pharmaceutical trials.
According to SCDM, edit checks are a crucial component of achieving error-free data.
“Trustworthy data are necessary for successful analysis and assessment in clinical research,” said Charlene Dark, CCDM, GCDMP Taskforce leader. “By publishing a set of best practices pertaining to edit check design, SCDM provides a foundation from which Clinical Data Management professionals can create comprehensive data cleaning to meet the highest level of data integrity.”
The new chapter focuses on creating efficient and accurate edit checks, automated review processes used to identify errors in data. It also discusses different types of edit checks and things to consider when working with them.
“The best practices outlined in Edit Check Design Principles are universal and can be applied in any clinical research setting-pharmaceutical, biotech or CRO, U.S.-based or international, paper trials or EDC,” said Melissa Lamb, who serves as a subject matter expert for SCDM’s GCDMP Taskforce. “This chapter is a guide for creating edit checks that result in the common goal of data quality and accuracy.”
The new text is available free to SCDM members, or by purchase to non-members, through the SCDM Web site. A podcast of the chapter is in production and scheduled for release this spring.
Moderna’s mRNA-1010 Flu Vaccine Meets Efficacy Goals in Phase III Trial of Adults 50+
July 10th 2025In the P304 Phase III study, Moderna’s mRNA-1010 demonstrated a 26.6% relative efficacy over a standard-dose flu vaccine in adults aged 50+, showing consistent protection across strains and age groups.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.